AwesomeCapital
Search This Blog
Monday, December 29, 2025
Praxis rises on ulixacaltamide gaining Breakthrough Therapy status
Praxis Precision Medicines gains FDA Breakthrough Therapy status for ulixacaltamide in essential tremor.
https://seekingalpha.com/news/4535694-praxis-rises-ulixacaltamide-gaining-breakthrough-therapy-status
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.